4-Cyanogramine

Catalog No.: 
ACJDYC089
CAS No.: 
105907-63-9
Molecular Formula: 
C12H13N3
Molecular Weight: 
199.26
4-Cyanogramine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$175.00InquiryInquiry
5g95%$486.00InquiryInquiry
10g95%$719.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Cyanogramine
IUPAC Name3-((dimethylamino)methyl)-1H-indole-4-carbonitrile
MDL No.MFCD11112015
Molecular FormulaC12H13N3
Molecular Weight199.26
SMILESCN(C)CC1=CNC2=C1C(C#N)=CC=C2
InChI KeyJYFDGWJTTRDEMP-UHFFFAOYSA-N
Synonym1H-Indole-4-carbonitrile, 3-[(dimethylamino)methyl]-
CAS No.105907-63-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJDYC089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACCQXK947 route compound structure diagram
    ACCQXK94716136-52-0In Stock
  6. Then
  7. ACJDYC089 route product structure diagram
    ACJDYC089105907-63-9
Inquiry

2. ACJDYC089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLFBH205 route compound structure diagram
    ACLFBH20553269-35-5In Stock
  4. Then
  5. ACJDYC089 route product structure diagram
    ACJDYC089105907-63-9
Inquiry

3. ACJDYC089 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJDYC089 route product structure diagram
    ACJDYC089105907-63-9
Inquiry

Comments (0)